Domača stranGEHC • NASDAQ
add
GE HealthCare Technologies Inc
76,44 $
Po zaprtju:(0,00 %)0,00
76,44 $
Konec trgovanja: 12. sep., 16:30:59 GMT -4 · USD · NASDAQ · Izjava
Prejšnji trg. dan.
77,96 $
Dnevni razpon
76,38 $ - 77,64 $
Letni razpon
57,65 $ - 94,80 $
Tržna kapitalizacija
34,90 mrd. USD
Povprečni obseg
3,43 mio.
Razm. P/E
15,65
Dividendna donosnost
0,18 %
Primarna borza
NASDAQ
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (USD) | jun. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 5,01 mrd. | 3,47 % |
Stroški poslovanja | 1,25 mrd. | −2,87 % |
Čisti dohodek | 486,00 mio. | 13,55 % |
Čista dobičkovnost prihodkov | 9,71 | 9,84 % |
Earnings per share | 1,06 | 6,00 % |
EBITDA | 880,00 mio. | 2,09 % |
Efektivna davčna stopnja | 18,43 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (USD) | jun. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 3,74 mrd. | 87,04 % |
Skupna sredstva | 35,50 mrd. | 11,45 % |
Skupne obveznosti | 25,55 mrd. | 7,08 % |
Celoten lastniški kapital | 9,95 mrd. | — |
Shares outstanding | 456,56 mio. | — |
Razmerje P/B | 3,67 | — |
Donosnost sredstev | 5,30 % | — |
Donosnost kapitala | 9,32 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (USD) | jun. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 486,00 mio. | 13,55 % |
Denar iz dejavnosti | 94,00 mio. | 178,99 % |
Denar iz naložb | −223,00 mio. | 36,10 % |
Denar iz financiranja | 1,36 mrd. | 2.487,72 % |
Neto sprememba denarnih sredstev | 1,29 mrd. | 335,83 % |
Prost denarni tok | −80,00 mio. | 8,57 % |
Vizitka
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.
The company's primary customers are hospitals and health networks. In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition.
The company operates in more than 100 countries. GE Healthcare has major regional operations in Buc, France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang, China; Hino & Tokyo, Japan, and Bangalore, India. Its biggest R&D center is in Bangalore, India, built at a cost of $50 million. Wikipedia
Generalni direktor
Datum ustanovitve
1994
Sedež organizacije
Spletno mesto
Zaposleni
53.000
